Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors

Lori A. Erickson, Long Jin, Peter C. Wollan, Geoffrey B. Thompson, Jon Van Heerden, Ricardo V. Lloyd

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Thyroid neoplasms represent a broad spectrum of tumors with different biologic behaviors. The majority of these tumors can be readily diagnosed by characteristic histopathologic features, but the distinction between follicular adenomas and follicular carcinomas can be difficult. Recent studies with cell cycle proteins such as p27(kip1) (p27), a cell cycle inhibitory protein, and Ki-67, a proliferation marker, suggest that these markers might be useful in predicting the behavior of various neoplasms. We analyzed 95 thyroid lesions (16 follicular adenomas, 23 follicular carcinomas, 22 papillary carcinomas, 27 anaplastic carcinomas, plus 7 non- neoplastic thyroids [NNTs], used as a control group) for expression of p27 and Ki-67 by immunostaining. The distribution of immunoreactivity was analyzed by quantifying nuclear staining in each case without knowledge of the diagnosis or outcome. Clinical history and follow-up information were obtained by chart review. There were significant differences in the expression of p27 between follicular adenomas (labeling index [LI] = 47.9 ± 5.6) and follicular carcinomas (LI = 15.7 ± 2.0). Papillary carcinomas (LI = 11.6 ± 3.0) and anaplastic carcinomas (LI = 9.4 ± 1.7) had p27 LIs similar to that of follicular carcinomas; the NNT group had the highest p27 LI (74.1 ± 4.9). The Ki-67 LI of anaplastic carcinomas (57.6 ± 3.8) was more than threefold greater than that of any other group. Logistic regression showed that p27 was effective in distinguishing follicular adenomas from follicular carcinomas (P = .0056) and that Ki-67 could also distinguish follicular adenomas from follicular carcinomas (P = .0060). Analysis of follicular carcinomas with and without metastases showed significantly higher expression of Ki-67 in patients with metastases (P = .0019). These results indicate that antibodies to p27 and Ki-67 might be useful in distinguishing between thyroid neoplasms that are difficult to diagnose by the usual histopathologic criteria.

Original languageEnglish (US)
Pages (from-to)169-174
Number of pages6
JournalModern Pathology
Volume11
Issue number2
StatePublished - Feb 1998

Fingerprint

Thyroid Gland
Carcinoma
Adenoma
Neoplasms
Cell Cycle Proteins
Papillary Carcinoma
Thyroid Neoplasms
Neoplasm Metastasis
Logistic Models
Staining and Labeling
Control Groups
Antibodies

Keywords

  • Ki-67
  • MIB-I
  • p27
  • Thyroid neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Erickson, L. A., Jin, L., Wollan, P. C., Thompson, G. B., Van Heerden, J., & Lloyd, R. V. (1998). Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors. Modern Pathology, 11(2), 169-174.

Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors. / Erickson, Lori A.; Jin, Long; Wollan, Peter C.; Thompson, Geoffrey B.; Van Heerden, Jon; Lloyd, Ricardo V.

In: Modern Pathology, Vol. 11, No. 2, 02.1998, p. 169-174.

Research output: Contribution to journalArticle

Erickson, LA, Jin, L, Wollan, PC, Thompson, GB, Van Heerden, J & Lloyd, RV 1998, 'Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors', Modern Pathology, vol. 11, no. 2, pp. 169-174.
Erickson LA, Jin L, Wollan PC, Thompson GB, Van Heerden J, Lloyd RV. Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors. Modern Pathology. 1998 Feb;11(2):169-174.
Erickson, Lori A. ; Jin, Long ; Wollan, Peter C. ; Thompson, Geoffrey B. ; Van Heerden, Jon ; Lloyd, Ricardo V. / Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors. In: Modern Pathology. 1998 ; Vol. 11, No. 2. pp. 169-174.
@article{d5a0d16e596c42d0b43b32e71c53cad7,
title = "Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors",
abstract = "Thyroid neoplasms represent a broad spectrum of tumors with different biologic behaviors. The majority of these tumors can be readily diagnosed by characteristic histopathologic features, but the distinction between follicular adenomas and follicular carcinomas can be difficult. Recent studies with cell cycle proteins such as p27(kip1) (p27), a cell cycle inhibitory protein, and Ki-67, a proliferation marker, suggest that these markers might be useful in predicting the behavior of various neoplasms. We analyzed 95 thyroid lesions (16 follicular adenomas, 23 follicular carcinomas, 22 papillary carcinomas, 27 anaplastic carcinomas, plus 7 non- neoplastic thyroids [NNTs], used as a control group) for expression of p27 and Ki-67 by immunostaining. The distribution of immunoreactivity was analyzed by quantifying nuclear staining in each case without knowledge of the diagnosis or outcome. Clinical history and follow-up information were obtained by chart review. There were significant differences in the expression of p27 between follicular adenomas (labeling index [LI] = 47.9 ± 5.6) and follicular carcinomas (LI = 15.7 ± 2.0). Papillary carcinomas (LI = 11.6 ± 3.0) and anaplastic carcinomas (LI = 9.4 ± 1.7) had p27 LIs similar to that of follicular carcinomas; the NNT group had the highest p27 LI (74.1 ± 4.9). The Ki-67 LI of anaplastic carcinomas (57.6 ± 3.8) was more than threefold greater than that of any other group. Logistic regression showed that p27 was effective in distinguishing follicular adenomas from follicular carcinomas (P = .0056) and that Ki-67 could also distinguish follicular adenomas from follicular carcinomas (P = .0060). Analysis of follicular carcinomas with and without metastases showed significantly higher expression of Ki-67 in patients with metastases (P = .0019). These results indicate that antibodies to p27 and Ki-67 might be useful in distinguishing between thyroid neoplasms that are difficult to diagnose by the usual histopathologic criteria.",
keywords = "Ki-67, MIB-I, p27, Thyroid neoplasms",
author = "Erickson, {Lori A.} and Long Jin and Wollan, {Peter C.} and Thompson, {Geoffrey B.} and {Van Heerden}, Jon and Lloyd, {Ricardo V.}",
year = "1998",
month = "2",
language = "English (US)",
volume = "11",
pages = "169--174",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Expression of p27(kip1) and Ki-67 in benign and malignant thyroid tumors

AU - Erickson, Lori A.

AU - Jin, Long

AU - Wollan, Peter C.

AU - Thompson, Geoffrey B.

AU - Van Heerden, Jon

AU - Lloyd, Ricardo V.

PY - 1998/2

Y1 - 1998/2

N2 - Thyroid neoplasms represent a broad spectrum of tumors with different biologic behaviors. The majority of these tumors can be readily diagnosed by characteristic histopathologic features, but the distinction between follicular adenomas and follicular carcinomas can be difficult. Recent studies with cell cycle proteins such as p27(kip1) (p27), a cell cycle inhibitory protein, and Ki-67, a proliferation marker, suggest that these markers might be useful in predicting the behavior of various neoplasms. We analyzed 95 thyroid lesions (16 follicular adenomas, 23 follicular carcinomas, 22 papillary carcinomas, 27 anaplastic carcinomas, plus 7 non- neoplastic thyroids [NNTs], used as a control group) for expression of p27 and Ki-67 by immunostaining. The distribution of immunoreactivity was analyzed by quantifying nuclear staining in each case without knowledge of the diagnosis or outcome. Clinical history and follow-up information were obtained by chart review. There were significant differences in the expression of p27 between follicular adenomas (labeling index [LI] = 47.9 ± 5.6) and follicular carcinomas (LI = 15.7 ± 2.0). Papillary carcinomas (LI = 11.6 ± 3.0) and anaplastic carcinomas (LI = 9.4 ± 1.7) had p27 LIs similar to that of follicular carcinomas; the NNT group had the highest p27 LI (74.1 ± 4.9). The Ki-67 LI of anaplastic carcinomas (57.6 ± 3.8) was more than threefold greater than that of any other group. Logistic regression showed that p27 was effective in distinguishing follicular adenomas from follicular carcinomas (P = .0056) and that Ki-67 could also distinguish follicular adenomas from follicular carcinomas (P = .0060). Analysis of follicular carcinomas with and without metastases showed significantly higher expression of Ki-67 in patients with metastases (P = .0019). These results indicate that antibodies to p27 and Ki-67 might be useful in distinguishing between thyroid neoplasms that are difficult to diagnose by the usual histopathologic criteria.

AB - Thyroid neoplasms represent a broad spectrum of tumors with different biologic behaviors. The majority of these tumors can be readily diagnosed by characteristic histopathologic features, but the distinction between follicular adenomas and follicular carcinomas can be difficult. Recent studies with cell cycle proteins such as p27(kip1) (p27), a cell cycle inhibitory protein, and Ki-67, a proliferation marker, suggest that these markers might be useful in predicting the behavior of various neoplasms. We analyzed 95 thyroid lesions (16 follicular adenomas, 23 follicular carcinomas, 22 papillary carcinomas, 27 anaplastic carcinomas, plus 7 non- neoplastic thyroids [NNTs], used as a control group) for expression of p27 and Ki-67 by immunostaining. The distribution of immunoreactivity was analyzed by quantifying nuclear staining in each case without knowledge of the diagnosis or outcome. Clinical history and follow-up information were obtained by chart review. There were significant differences in the expression of p27 between follicular adenomas (labeling index [LI] = 47.9 ± 5.6) and follicular carcinomas (LI = 15.7 ± 2.0). Papillary carcinomas (LI = 11.6 ± 3.0) and anaplastic carcinomas (LI = 9.4 ± 1.7) had p27 LIs similar to that of follicular carcinomas; the NNT group had the highest p27 LI (74.1 ± 4.9). The Ki-67 LI of anaplastic carcinomas (57.6 ± 3.8) was more than threefold greater than that of any other group. Logistic regression showed that p27 was effective in distinguishing follicular adenomas from follicular carcinomas (P = .0056) and that Ki-67 could also distinguish follicular adenomas from follicular carcinomas (P = .0060). Analysis of follicular carcinomas with and without metastases showed significantly higher expression of Ki-67 in patients with metastases (P = .0019). These results indicate that antibodies to p27 and Ki-67 might be useful in distinguishing between thyroid neoplasms that are difficult to diagnose by the usual histopathologic criteria.

KW - Ki-67

KW - MIB-I

KW - p27

KW - Thyroid neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0031594658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031594658&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 169

EP - 174

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 2

ER -